Blackstone Life Sciences and Anthos Therapeutics Announce Agreement for Anthos to be Acquired by Novartis for up to $3.1 BillionBusiness Wire • 02/11/25
Novartis bolsters late-stage cardiovascular pipeline with agreement to acquire Anthos Therapeutics for USD 925 million upfrontGlobeNewsWire • 02/11/25
Novartis Rises 5% Since Q4 Earnings: How Should You Play the Stock?Zacks Investment Research • 02/06/25
Novartis Edges Higher On Sales Beat As Competition Looms For Its Biggest MoneymakerInvestors Business Daily • 01/31/25
Novartis continues strong momentum of sales growth with margin expansion, reaches key innovation milestones in 2024GlobeNewsWire • 01/31/25
Novartis And BioAge Team Up To Develop Aging Therapies And Boost Investor PotentialSeeking Alpha • 01/13/25